U2Af2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| | |
|---|---|
| **Gene Symbol** | U2AF2 |
| **Full Name** | U2AF Auxiliary Factor 2 |
| **Chromosomal Location** | 19q13.42 |
| **NCBI Gene ID** | [11321](https://www.ncbi.nlm.nih.gov/gene/11321) |
| **OMIM ID** | [605024](https://www.omim.org/entry/605024) |
| **Ensembl ID** | ENSG00000163251 |
| **UniProt ID** | [P26368](https://www.uniprot.org/uniprot/P26368) |
| **Associated Diseases** | ALS, Neurodegeneration |
U2AF2 (U2AF65) is a key splicing factor that recognizes the 3' splice site of pre-mRNA. It binds to the polypyrimidine tract and the AG acceptor site, facilitating recruitment of the U2 snRNP to the branch point.
The study of U2Af2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The U2AF2 Gene is involved in various cellular processes in the nervous system. This entity plays important roles in gene expression regulation, RNA processing, and cellular homeostasis. Dysfunction has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
The U2AF2 Gene participates in multiple molecular pathways critical for neuronal health. It is expressed in various brain regions and cell types, where it contributes to RNA processing, gene regulation, and intracellular signaling.
Alterations in U2AF2 Gene expression or function have been associated with several neurodegenerative conditions. Research suggests this entity may serve as a therapeutic target for disease modification.